Stock Score Locked: Want to See it? Benzinga Rankings give you vital metrics on any stock – anytime.
Medical Device Network on MSN
Insulet initiates Omnipod 5 recall following 18 AE reports
Insulet estimates that the pods involved in this correction represent approximately 1.5% of annual production globally.
The correction is related to the Omnipod 5 Controller charging port (USB-C port) or cable (USB cable) melting, deforming, or discoloring. Insulet Corporation has voluntarily issued a Medical Device ...
The US FDA has cleared the first updates to the algorithm of the Omnipod 5 automated insulin delivery (AID) system (Insulet Corporation) since its launch in 2022. Omnipod 5, the only tubing-free pump ...
New 100 mg/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mode to improve the user experience. Most requested ...
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...
ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod ® 5 App for iPhone is now compatible with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results